Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04644796 · ClinicalTrials.gov registry record · Phase 4
A Randomized Trial of Exparel vs Saline in Opioid Reduction of Pain Management Following Lumbar Spine Surgeries.
A Phase 4 study of Lumbar Spine Degeneration, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
- 1
- Study location
NCT04644796: Completed Phase 4 study of Lumbar Spine Degeneration, sponsored by University of Missouri-Columbia.
NCT04644796 is a Phase 4 study of Lumbar Spine Degeneration that has completed, run by University of Missouri-Columbia. The registered enrollment target is 34 participants, below the 639-participant average among 7 other Lumbar Spine Degeneration trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04644796, a Phase 4 study of Lumbar Spine Degeneration, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to establish a relationship between liposomal bupivacaine surgical site injection and postop opioid utilization.
Primary Outcome
Comparing post operative opioid usage reduction between treatment and placebo group.
Conditions Studied
Interventions
- DRUG Liposomal bupivacaine
- DRUG saline 0.9%
Study Locations (1)
Missouri
- Missouri Orthopaedic Institute - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2021-02-10 |
| Est. Completion | 2022-06-13 |
| Phase | Phase 4 |
What the finished NCT04644796 record still lists
NCT04644796 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 639-participant average among 7 other Lumbar Spine Degeneration trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Lumbar Spine Degeneration appearing as the primary indexed condition, and to 2 interventions - of which Liposomal bupivacaine is the first listed.
NCT04644796 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT04644796 about?
NCT04644796 is a clinical study titled "A Randomized Trial of Exparel vs Saline in Opioid Reduction of Pain Management Following Lumbar Spine Surgeries.". The purpose of this study is to establish a relationship between liposomal bupivacaine surgical site injection and postop opioid utilization.
What is the current status of trial NCT04644796?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2021-02-10. Estimated completion is 2022-06-13.
What conditions does trial NCT04644796 study?
This clinical trial studies the following conditions: Lumbar Spine Degeneration.
What interventions are being tested in trial NCT04644796?
The interventions under investigation include: Liposomal bupivacaine (DRUG), saline 0.9% (DRUG).
Who is sponsoring clinical trial NCT04644796?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04644796 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lumbar Spine Degeneration
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion
RECRUITING · Phase 4
-
LDGraft in Single Level Anterior Lumbar Interbody Fusion (ALIF)
RECRUITING · Phase 1
-
OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults
RECRUITING
-
The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions
RECRUITING · NA
-
3Spine Lumbar Fusion Real World Evidence Study
ACTIVE NOT RECRUITING
-
MOTUS Total Joint Replacement Investigational Device Exemption Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI